Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1985
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: GLP-compliant study, similar to OECD testing guideline.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1985
Report date:
1985

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
Deviations:
yes
Remarks:
Only 1000 cells per dose group scored.
GLP compliance:
yes
Remarks:
Genetic Toxicology, CIBA-GEIGY Ltd., Basle, Switzerland
Type of assay:
other: Nucleus Anomaly Test

Test material

Constituent 1
Chemical structure
Reference substance name:
-
EC Number:
400-820-2
EC Name:
-
Cas Number:
84268-33-7
Molecular formula:
C20 H23 N3 O3
IUPAC Name:
methyl 3-[3-(2H-1,2,3-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl]propanoate
Details on test material:
- Physical state: solid
- Analytical purity: purified
- Lot/batch No.: Z 288/1U

Test animals

Species:
hamster, Chinese
Strain:
not specified
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: 4 - 9 weeks
- Weight at study initiation: female: 21-29 g, male: 21-32 g
- Assigned to test groups randomly: [no/yes, under following basis: ]
- Fasting period before study:
- Housing:
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period:

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23-24
- Humidity (%): 56 - 58
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
- Vehicle(s)/solvent(s) used: 0.5% aqueous solution of sodium-carboxylmethylcellulose + 0.1% Tween 80
Duration of treatment / exposure:
2 days
Frequency of treatment:
daily
Post exposure period:
24 hours
Doses / concentrations
Remarks:
Doses / Concentrations:
560, 1120, 2240 mg/kg
Basis:
actual ingested
No. of animals per sex per dose:
6
Control animals:
yes, concurrent vehicle
Positive control(s):
cyclophosphamide
- Route of administration: oral gavage
- Doses / concentrations: 128 mg/kg bw / 20mL/kg

Examinations

Tissues and cell types examined:
bone marrow
Details of tissue and slide preparation:
DETAILS OF SLIDE PREPARATION: Small drops of the mixture were transferred on the end of a slide, spread out by pulling it behind a polished cover glass and the preparations were air-dried. Three hours later, the slides were stained in undiluted May-Gruenwald solution for 2 min then in May-Gruenwald solution/water 1/1 for 2 min and then in Giemsa's, 40% for 20 min. After being rinsed in methanol 55% for 5-8 sec and washed off twice in water,
they were left immersed in water for approx. 2 min. After rinsing with distilled water and air-drying, the slides were cleared in Xylene and mounted in Eukitt.

METHOD OF ANALYSIS: The slides of three female and three male animals each of the negative control group, the positive control group and of the groups treated with various doses were examined, 1000 bone marrow cells each were scored per animal and the following anomalies were
registered:
a) Single Jolly bodies, b) fragments of nuclei in erythrocytes, c) micronuclei in erythroblasts, d) micronuclei in leucopoietic cells, e) polyploid cells,

Evaluation criteria:
1,000 Bone marrow cells were scored from each animals and the following anomalies were registered:

a) Single Jolly bodies,
b) fragments of nuclei in erythrocytes,
c) micronuclei in erythroblasts,
d) micronuclei in leucopoietic cells,
e) bizarre forms of nuclei,
f) polyploid cells and
g) necrobiotic cells
Statistics:
The significance of difference was assessed by chi-square-test.

Results and discussion

Test results
Sex:
male/female
Genotoxicity:
negative
Toxicity:
no effects
Vehicle controls validity:
valid
Negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
RESULTS OF DEFINITIVE STUDY
One female animal of the positive control group died in the course of the experiment.
The bone marrow smears from animals treated with the various doses showed no significant difference from the control. The incidence of bone marrow cells with anomalies of nuclei corresponds to the frequency observed in the control group.
By contrast, a "positive control" experiment with cyclophosphamide (128 mg/kg) yielded 9,87% cells with anomalies of nuclei. This is significantly different from the controls (0,15%) treated with the vehicle (0,5% CMC +0,1% Tween 80) alone (see attached table)

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): negative